Quick Answer Agassi Sports Entertainment Corp. reported Stockholders Equity of $306.0 thousand for fiscal year 2025. Agassi Sports Entertainment Corp. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $306.0K -86.6% 2024 $2.28M +474.0% 2023 -$610.2K -12.9% 2023 -$540.4K +0.0% 2022 -$540.4K -11.9% 2021 -$482.9K -25.6% 2020 -$384.6K -22.6% 2019 -$313.8K -36.5% … Read more
Quick Answer Agassi Sports Entertainment Corp. reported Cash and Equivalents of $95.7 thousand for fiscal year 2025. Agassi Sports Entertainment Corp. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $95.7K -95.9% 2024 $2.32M +39504.5% 2015 $5.9K +166.2% 2014 $2.2K — 2013 $0.00 -100.0% 2012 $5.5K +189.5% 2011 $1.9K -82.2% … Read more
Quick Answer Agassi Sports Entertainment Corp. reported Total Assets of $800.4 thousand for fiscal year 2025. Agassi Sports Entertainment Corp. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $800.4K -65.6% 2024 $2.33M +6129005.3% 2023 $38.00 +0.0% 2022 $38.00 -40.6% 2021 $64.00 -7.2% 2020 $69.00 +86.5% 2019 $37.00 -99.7% 2018 $14.2K -50.0% … Read more
Quick Answer Agassi Sports Entertainment Corp. reported Net Income of -$9.49 million for fiscal year 2025. Agassi Sports Entertainment Corp. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$9.49M -1095.8% 2024 -$793.7K -1036.0% 2023 -$69.9K -21.7% 2022 -$57.4K +41.6% 2021 -$98.4K -38.9% 2020 -$70.8K +15.5% 2019 -$83.8K -113.3% 2016 $628.0K -12.7% … Read more
Quick Answer Agassi Sports Entertainment Corp. reported Total Revenue of $2.02 million for fiscal year 2015. Agassi Sports Entertainment Corp. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2015 $2.02M -5.4% 2014 $2.13M +1.9% 2013 $2.09M -1.7% 2012 $2.13M +0.3% 2011 $2.12M +8.3% 2010 $1.96M — Quarterly Total Revenue Quarter Ending Total … Read more
Quick Answer Agassi Sports Entertainment Corp. reported Total Revenue of $2.02 million for fiscal year 2015. Agassi Sports Entertainment Corp. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue — — — — — — Net Income -$9.49M-1095.8% -$793.7K-1036.0% -$69.9K-21.7% -$57.4K+41.6% -$98.4K-38.9% -$70.8K+15.5% Total Assets $800.4K-65.6% $2.33M+6129005.3% $38.00+0.0% $38.00-40.6% $64.00-7.2% … Read more
Quick Answer Aardvark Therapeutics, Inc. reported Shares Outstanding of 21.82 million shares for fiscal year 2025. Aardvark Therapeutics, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 21.82M +436.4% 2024 4.07M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ September 30, 2025 21.75M — +0.2% June 30, 2025 21.69M … Read more
Quick Answer Aardvark Therapeutics, Inc. reported R&D Expense of $48.94 million for fiscal year 2025. Aardvark Therapeutics, Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $48.94M +181.8% 2024 $17.36M — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ September 30, 2025 $13.74M +237.9% +4.5% June 30, 2025 $13.14M +226.3% … Read more
Quick Answer Aardvark Therapeutics, Inc. reported Operating Income of -$62.73 million for fiscal year 2025. Aardvark Therapeutics, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$62.73M -175.3% 2024 -$22.79M — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ September 30, 2025 -$17.70M -247.7% -11.7% June 30, 2025 -$15.85M -161.0% … Read more
Quick Answer Aardvark Therapeutics, Inc. reported Cash and Equivalents of $47.05 million for fiscal year 2025. Aardvark Therapeutics, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $47.05M -23.7% 2024 $61.64M — Quarterly Cash and Equivalents Quarter Ending Cash and Equivalents YoY QoQ September 30, 2025 $39.28M — +51.1% … Read more